Based on the putative anti-inflammatory role of p62, together with the fact that p62 physiologically controls osteoclastogenesis and bone remodeling [17], we hypothesized that p62 DNA vaccine could compensate for osteoporosis. The gene discussed is SQSTM1; the disease is osteoporosis.